Q4 2020 earnings

The company boasted strong revenues and membership growth but took a hit in its GAAP net income.
GoodRx closes first year as a public company in Q4 2020 earnings call
By Mallory Hackett | 01:13 pm | March 12, 2021
The company boasted strong revenues and membership growth but took a hit in its GAAP net income.
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.
Dexcom comes out on top of its 2020 financial goals
By Mallory Hackett | 01:02 pm | February 12, 2021
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.